Latest From Biotech Now

BIO Gearing Up to Announce the 2014 Washington Carver Award Recipient

World Congress

BIO will present the 7th annual George Washington Carver Award to a key innovator who has changed the landscape for the industrial biotechnology industry at its annual World Congress on Industrial Biotechnology which will be held May 12-15, 2014 in Philadelphia, PA. This award emphasizes the important goal of using biotech innovation to develop sustainable bio-based value-chains. Born in slavery, around 1864, George Washington Carver became a prominent leader in the field of plant biology, Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Cancer Insurance Checklist: Guía de Cobertura Médica para Personas con Cáncer

20070112

As the world marks World Cancer Day and the U.S. continues to implement the Affordable Care Act, the Cancer Support Community (CSC) is pleased to announce the launch of a Spanish language version of the successful resource, the Cancer Insurance Checklist. This easy-to-use guide is available to assist people with cancer, a history of cancer or at risk for cancer choose a health insurance plan. The need is great.  Nearly a third (31.1 percent) of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Report Shows World’s Weakest IP Environments

admin-ajax

There is clear link between a country’s rate of economic development and the strength of its intellectual property laws. This is particularly true in knowledge-intensive sectors such as biopharmaceuticals. The good news is that some mature and emerging economies are making growing use of patent systems to facilitate biotechnology research and commercialization. The bad news is that a number of countries, including India, China, Brazil and Canada, have established bureaucratic and burdensome hurdles to patentability. Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Responds to GPhA Citizen Petition on Biosimilars Naming

FDA115x76

Last September, the Generic Pharmaceutical Association (GPhA) filed a Citizen Petition with the FDA, requesting the FDA to “implement its INN naming policy equally to all biologics” and to require “all biologics approved under the Section 351(k) pathway…share the same INN [International Nonproprietary Name] as the RPP [reference protein product]” (the GPhA Petition). Today, BIO submitted our response. Contrary to the GPhA Petition, BIO believes that the legal, regulatory, and scientific principles related to biologics and biosimilarity Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO CEO Company Snapshot: Tetraphase Pharmaceuticals

tetraphase

The BIO CEO & Investor Conference is now just a week away, and buzz for the event has never been greater. Tomorrow, Inside BIO is hosting its first ever twitter chat to discuss the annual buyside survey, which has been getting great responses from the investor community. Presentation spots are still sold out as well, and we’re continuing to highlight those companies slated to present. One such company is Tetraphase Pharmaceuticals, who went public this Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , ,